EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study

PURPOSE: We aimed to evaluate whether the addition of pemetrexed is effective in improving progression-free survival (PFS) in epidermal growth factor receptor (EGFR)–mutated patients with or without concomitant alterations. MATERIALS AND METHODS: This multicenter clinical trial was conducted in Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Weiguang, Zhang, Hua, Lu, Yiyu, Li, Minjing, Yang, Shuang, Liang, Jianmiao, Ye, Zhijian, Li, Zhihua, He, Minhong, Shi, Xiaoliang, Wang, Fei, You, Dong, Gu, Weiquan, Feng, Weineng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372607/
https://www.ncbi.nlm.nih.gov/pubmed/36791768
http://dx.doi.org/10.4143/crt.2022.1438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372607/
https://www.ncbi.nlm.nih.gov/pubmed/36791768
http://dx.doi.org/10.4143/crt.2022.1438

Ejemplares similares